Yahoo! Finance Search - Finance Home - Yahoo! - Help

Tuesday, July 29 2014 8:56am ET - U.S. Markets open in 34 minutes.
Industry Center - Drug Manufacturers - Other
Industry Center > Drug Manufacturers - Other > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Manufacturers - Other News
Latest News
Tuesday, Jul 29, 2014
·United Therapeutics Corporation Reports Second Quarter 2014 Financial Results
PR Newswire - 2 hours, 56 minutes ago
Monday, Jul 28, 2014
·Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014
PR Newswire - Mon 7:00 pm ET
·Will Merck & Co. (MRK) Surprise This Earnings Season? - Mon 4:28 pm ET
·Is Pfizer Inc. (PFE) Poised to Beat Earnings Estimates? - Mon 4:20 pm ET
·Will Vertex Pharmaceuticals (VRTX) Loss be Below Estimates? - Mon 3:30 pm ET
·U.S. FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications
PR Newswire - Mon 1:18 pm ET
·[video] Allergan's Largest Shareholder Sells Most of Holdings
at MarketWatch - Mon 11:05 am ET
·Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call
PR Newswire - Mon 7:00 am ET
·Biodel Enters Into $15 Million Equity Commitment With Lincoln Park Capital
Marketwire - Mon 6:00 am ET
Friday, Jul 25, 2014
·Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014
PR Newswire - Fri Jul 25
·Allergan gets EU recommendation on new use of eye drug
Reuters - Fri Jul 25
·Pernix Therapeutics to Report Second Quarter 2014 Financial Results on August 11, 2014
Business Wire - Fri Jul 25
·European Medicines Agency (EMA) Issues Positive Opinion, Recommends Full Approval of IMBRUVICA® (ibrutinib) for Treatment of Two Blood Cancers
PR Newswire - Fri Jul 25
·Allergan Announces OZURDEX® (dexamethasone 700 mcg intravitreal implant in applicator) Receives European Positive Opinion for the Treatment of Diabetic Macular Edema
Business Wire - Fri Jul 25
·Novo Nordisk receives positive opinion from CHMP
- Fri Jul 25
·EMA recommends approval for Novo Nordisk diabetes treatment
- Fri Jul 25
Thursday, Jul 24, 2014
·Endo completes acquisition of Grupo Farmaceutico Somar®
PR Newswire - Thu Jul 24
·What Gilead Stock's Latest Blockbuster Approval Means for Investors
at Motley Fool - Thu Jul 24
·POZEN Announces August 7th Webcast of Second Quarter 2014 Results
Business Wire - Thu Jul 24
·If Valeant Buys Allergan, Many Docs Will Shift Business, a Survey Finds
at The Wall Street Journal Online - Thu Jul 24
More Latest News...
Sponsor Results
Professional Statistician
All areas of research. Free initial consultation. 877-461-7226
Accelerated Study Start
Clinical trial site identification, feasibility, and activation.
ChainStoreGuide Newsroom
Get Industry News & Insights By Our Experienced Editorial Staff.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Other Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?